All News #Library
Others
Sage Therapeutics Reports Topline Results from Pivotal Phase 3 MOUNTAIN Study
05 Dec 2019 //
BUSINESSWIRE
Sage strategy for postpartum depression drug Zulresso keys on patient support
01 Jul 2019 //
FIERCE PHARMA
Sage gets US approval for first postpartum depression therapy
21 Mar 2019 //
NIH

Market Place
Sourcing Support